Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-09-15FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for escitalopram oxalate from Rising Pharma Holdings, Inc., enabling the marketing of a generic …
-
FDA approval · 2014-08-25FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Strides Pharma Inc.)
FDA approved the original application for buspirone hydrochloride (generic) from Strides Pharma Inc., signaling the availability of a generi…
-
FDA approval · 2014-08-08FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Alprazolam from Mylan Pharmaceuticals Inc., indicating regulatory approval for a supplementa…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-07-17FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s supplemental application for doxepin hydrochloride, updating the previously approved abbreviated new drug appl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic) from Dr. Reddy's Laboratories Limited. This action approves …
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' supplemental application for a generic venlafaxine product (ANDA 078932). Venlafaxine is indicated…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride, a generic venlafaxine product from Aurobindo Pharma Limited.
-
FDA approval · 2014-07-08FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, Inc.
-
FDA approval · 2014-06-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., marking an approval action un…
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for venlafaxine submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2014-06-18FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2014-06-17FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for venlafaxine from BluePoint Laboratories under ANDA077653. This action authorizes a generic versi…
-
FDA approval · 2014-06-11FDA Approved: DULOXETINE DELAYED-RELEASE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical's original generic duloxetine hydrochloride delayed-release capsules, a generic version of the anti…
-
FDA approval · 2014-06-09FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for duloxetine hydrochloride, establishing a generic version of duloxetine.
-
FDA approval · 2014-05-20FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for escitalopram oxalate by Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2014-02-07FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for Buspirone hydrochloride (generic). The approval marks entry of a generic version manufactured by Z…
-
FDA approval · 2014-01-10FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc., authorizing its manufacturing and…
-
FDA approval · 2014-01-08FDA Approved: DULOXETINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a duloxetine generic from Zydus Lifesciences Limited, enabling marketing for the same indications …
-
FDA approval · 2013-12-31FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic paroxetine hydrochloride product manufactured by NorthStar Rx LLC.
-
FDA approval · 2013-12-31FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Paroxetine hydrochloride hemihydrate from Mylan Pharmaceuticals, confirming the continued author…
-
FDA approval · 2013-12-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Venlafaxine Hydrochloride by Aurobindo Pharma Limited, updating the regulatory status of thi…
-
FDA approval · 2013-12-19FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine submitted by Padagis US LLC (NDA 204516).
-
FDA approval · 2013-12-19FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC under ANDA202227, enabling continued co…